NxStage Medical, Inc. (NASDAQ:NXTM)
CAPS Rating:
A medical device company, which develops, manufactures and markets innovative systems for the treatment of end-stage renal disease and acute kidney failure.
A medical device company, which develops, manufactures and markets innovative systems for the treatment of end-stage renal disease and acute kidney failure.
Recs
If there's one thing I've learned, it's that when a stock is at its 52 week low, it's probably going to go lower before it goes higher. Don't try to find the bottom.